GraniteShares’ XOUT ETF Celebrates One-Year Anniversary
07. Oktober 2020 08:45 ET
|
GraniteShares
ETF outperforms S&P 500 by 11.34% in first year by seeking to eliminate losing stocks; Accumulates $78 million in assets NEW YORK, Oct. 07, 2020 (GLOBE NEWSWIRE) -- The GraniteShares...
Dr. Gregory Jantz of The Center • A Place of HOPE celebrates 30 years of helping reduce veteran suicide
01. November 2019 17:00 ET
|
The Center A Place of HOPE
Edmonds, WA, Nov. 01, 2019 (GLOBE NEWSWIRE) -- Depression suicide amongst veterans has always been a concern for policymakers. Research shows that, veterans have a 21% higher likelihood of suicide...
Dr. Gregory Jantz is proud to inform you of his new book – Healing Depression for Life
09. September 2019 22:00 ET
|
The Center A Place of HOPE
Edmonds, WA, Sept. 09, 2019 (GLOBE NEWSWIRE) -- It is with great honor that Dr. Gregory Jantz is announcing the release of his latest book titled, Healing Depression for Life. The book is as...
ContraFect Corporation to Present at the 13th Annual BIO Investor Forum
30. September 2014 07:30 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Sep 30, 2014) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company focused on the discovery and development of protein...
ContraFect Corporation Expands Senior Management Team
24. September 2014 07:30 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Sep 24, 2014) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company focused on the discovery and development of protein...
ContraFect Corporation to Present at BioCentury's 21st Annual NewsMakers in the Biotech Industry Conference
19. September 2014 07:30 ET
|
ContraFect Corporation
YONKERS, NEW YORK--(Marketwired - Sep 19, 2014) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company focused on protein and antibody therapeutic products...
ContraFect Corporation's Universal Influenza Treatment Receives SBIR Funding
16. September 2014 07:30 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Sep 16, 2014) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company focused on the discovery and development of protein...
ContraFect Corporation Announces Separation of Units Sold in IPO
09. September 2014 07:30 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Sep 9, 2014) - ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious...
ContraFect Corporation to Present at the Rodman & Renshaw 16th Annual Healthcare Conference
03. September 2014 07:30 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Sep 3, 2014) - ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious...
ContraFect Corporation Showcases CF-301 at ICAAC 2014 Meeting in Washington, D.C.
02. September 2014 17:00 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Sep 2, 2014) - ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious...